Taysha Share Price

Taysha Share Price

NASDAQ: TSHA | Small Cap | Healthcare
$3.71
-$0.05 (-1.33%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Taysha Stock Performance

Open
$3.66
Prev. Close
$3.75
Circuit Range
N/A
Day Range
$3.64 - $3.79
Year Range
$3.47 - $7.30
Volume
2,35,397
Average Traded
$3.73

Taysha Share Price Today

As of 21 November 2026, Taysha Gene Therapies, Inc.'s share price is $3.71. The stock opened at $3.66, compared to its previous close of $3.75. During today's trading session, Taysha Gene Therapies, Inc.'s share price traded between $3.64 and $3.79, with an average price of $3.71. Over the past 52 weeks, the stock has recorded a high of $7.30 and a low of $3.47. In terms of performance, Taysha Gene Therapies, Inc.'s share price has declined by 36.67% over the last six months and is down 21.84% on a year-on-year basis.

Taysha Share Price Chart

Line chart of the Taysha price trend over the selected period. The price fell overall, ranging from 3.66 to 3.79, ending at 3.71.
$3.64$3.79
L
Show Current Price
H

Taysha Stock Fundamentals & Key Indicators

Market Cap
$1.18B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$9.77B
Return On Equity (TTM)
-43.71%
Profit Margin
-1115.66%
Debt to Equity
0.13
Quarterly Earnings Growth YoY
-40.50%

Taysha Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$5.49$0.00$0.00$0.00
Net Profit-$27.85-$42.41-$46.64-$39.13
Net Profit Margin-507.29%N/AN/AN/A
Income ChangeN/A-52.28%-9.97%16.10%

Taysha Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.50$15.45$8.33$9.77
Net Profit-$166.01-$111.57-$89.30-$109.00
Net Profit Margin-6640.40%-722.14%-1072.03%-1115.66%
Income ChangeN/A32.79%19.96%-22.06%

Taysha Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets18.6718.2322.8629.86
Current Assets324.65142.13149.8796.42
Total Assets343.32160.36172.73126.28
Non Current Liabilities69.8362.6161.0462.54
Current Liabilities26.5526.2336.7662.79
Total Liabilities96.3888.8497.79125.33
Shareholders' Equity246.9471.5374.940.95

Taysha Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-93.09-81.23-73.02-92.64
Investing-0.6-0.36-7.35-20.68
Financing274.5976.68136.3952.1

About Taysha

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Taysha Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.18
$3.71
-10.07%
Oct 2026
$4.83
$4.12
-15.40%
Sep 2026
$5.63
$4.87
-18.15%
Aug 2026
$5.90
$5.95
+1.45%
Jul 2026
$6.71
$5.87
-13.94%
Jun 2026
$5.79
$6.82
+16.50%
May 2026
$6.33
$5.85
-8.16%
Apr 2026
$4.41
$6.37
+42.99%
Mar 2026
$4.47
$4.46
-1.87%
Feb 2026
$4.61
$4.54
+0.55%
Jan 2026
$5.48
$4.51
-17.76%
Dec 2025
$4.60
$5.49
+15.82%

Taysha Share Price FAQs